NovaCell Technology Inc.
1 clinical trials · Sponsor
◉ Watch NovaCell Technology Inc.
| Record | Firm | Date |
|---|---|---|
| A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112 (NCT05638165) | NovaCell Technology Inc. | 2021-10-13 |
Track NovaCell Technology Inc. automatically
Every clearance here is in the API, with alerts when new ones post.